Overview / Abstract: |
In this video-based activity, Dr. Dinesh Khanna shares the importance of screening patients with connective tissue disease for pulmonary arterial hypertension to facilitate earlier diagnosis and improve patient outcomes. Dr. Khanna discusses the impact of delayed diagnosis, screening protocols, barriers to physician adherence, and the importance of a multidisciplinary team. A patient case offers real-world insight and key takeaways for application to clinical practice. The purpose of this activity is to enhance clinician skills in the recognition and diagnosis of CTD-PAH in order to improve patient outcomes. Through a review of screening guidelines and the latest clinical data, this activity provides practical guidance to improve early detection and effectively work in a multidisciplinary team. |
Expiration |
Sep 09, 2021 |
Discipline(s) |
Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME |
Format |
Webinar / Webcast / Video |
Credits / Hours |
.50 AMA PRA Category 1 Credit(s)™ |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Dinesh Khanna, MD, MSc |
Activity Specialities / Related Topics |
Family Medicine, Internal Medicine, Primary Care, Pulmonary Medicine / COPD, Rheumatology / Arthritis |
Sponsors / Supporters / Grant Providers |
This activity is supported by an educational grant from Bayer HealthCare Pharmaceuticals, and Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson. |
Keywords / Search Terms |
ACHL Free CE CME |